Walleye Capital’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$332K Sell
97,200
-71,500
-42% -$241K ﹤0.01% 2993
2025
Q4
$477K Buy
+168,700
New +$870K ﹤0.01% 2987
2025
Q3
Sell
-26,600
Closed -$157K 4473
2025
Q2
$157K Sell
26,600
-43,000
-62% -$247K ﹤0.01% 3537
2025
Q1
$445K Buy
69,600
+35,700
+105% +$344K ﹤0.01% 2643
2024
Q4
$403K Buy
33,900
+8,400
+33% +$143K ﹤0.01% 3163
2024
Q3
$706K Buy
25,500
+800
+3% +$20K ﹤0.01% 2979
2024
Q2
$589K Buy
+24,700
New +$580K ﹤0.01% 3371
2024
Q1
Sell
-15,400
Closed -$243K 5401
2023
Q4
$243K Buy
15,400
+6,600
+75% +$68.1K ﹤0.01% 3534
2023
Q3
$75.7K Buy
+8,800
New +$62.5K ﹤0.01% 4061
2023
Q2
Sell
-100
Closed -$745 4294
2023
Q1
$745 Buy
+100
New +$994 ﹤0.01% 3844

Other funds holding ASPN

Walleye Capital's ASPN Position: Q1 2026 in Review

Walleye Capital sold out of Aspen Aerogels (ASPN) in Q1 2026, closing a stake of 834 shares — an estimated $2.81K sold.

Walleye Capital first reported a position in ASPN in Q4 2021 and held it in 8 quarters. The position peaked at $1.65M in Q2 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Walleye Capital reported no remaining Aspen Aerogels position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 834 Aspen Aerogels shares in Q1 2026, an estimated $2.81K.
  • Walleye Capital first reported a position in Aspen Aerogels in Q4 2021 and held it in 8 quarters.
  • Walleye Capital's Aspen Aerogels position peaked at $1.65M in Q2 2024.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.